Cytokinetics Announces Non-Clinical Data From Multiple Programs To Be Presented At The Biophysical Society 54th Annual Meeting
Main Category: Biology / BiochemistryArticle Date: 16 Feb 2010 - 5:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
Cytokinetics, Incorporated (NASDAQ: CYTK) announced that five abstracts regarding its research programs are scheduled to be presented as poster presentations at the Biophysical Society 54th Annual Meeting to be held February 20-24, 2010 at the Moscone Center in San Francisco, California. The posters summarize non-clinical findings in Cytokinetics' skeletal and smooth muscle contractility programs, as well as other prior research.
Poster Presentations at Biophysical Society 54th Annual Meeting
The following abstracts are scheduled to be presented at the Biophysical Society 54th Annual Meeting:
Abstract #778-Pos: "The Small Molecule Skeletal Sarcomere Activator, CK-2017357, is a Calcium Sensitizer that Binds Selectively to the Fast Skeletal Troponin Complex." The poster presentation is scheduled on Sunday, February 21, 2010 during the Muscle Regulation I Poster Session in Hall D of the Moscone Center. The presenter, Raja Kawas, Cytokinetics, Inc., South San Francisco, CA will be present from 1:45 PM - 2:45 PM at poster board #B659.
Abstract #860-Pos: "The Molecular Mechanism of the Multi Tasking Kinesin-8 Motor." The poster presentation is scheduled on Sunday, February 21, 2010 during the Microtubule Motors-Kinesin-related Proteins Poster Session in Hall D of the Moscone Center. The presenter, Carolyn Moores, Ph.D., Birkbeck College, London, United Kingdom will be present from 1:45 PM - 2:45 PM at poster board #B741.
Abstract #1831-Pos: "The Small Molecule Smooth Muscle Myosin Inhibitor, CK-2018571, Selectively Inhibits ATP Hydrolysis and Relaxes Smooth Muscle in vitro." The poster presentation is scheduled on Monday, February 22, 2010 during the Muscle Regulation II Poster Session in Hall D of the Moscone Center. The presenter, Sheila Clancy, Cytokinetics, Inc., South San Francisco, CA will be present from 1:45 PM - 2:45 PM at poster board #B629.
Abstract #2803-Pos: "The Fast Skeletal Troponin Activator, CK-1909178 Reduces Muscle Fatigue in a Model of Peripheral Artery Disease in situ." The poster presentation is scheduled on Tuesday, February 23, 2010 during the Muscle: Fiber & Molecular Mechanics & Structure III Poster Session in Hall D of the Moscone Center. The presenter, Aaron Hinken, Ph.D., Cytokinetics, Inc., South San Francisco, CA will be present from 1:45 PM - 2:45 PM at poster board #B532.
Prior research from Cytokinetics' oncology program is also scheduled to be presented as part of a presentation during the Motility Subgroup Evening Talk on Saturday, February 20, 2010 at 8:00 PM, given by Steven S. Rosenfeld, M.D., Ph.D., Columbia University, New York, NY.
Source
Cytokinetics
Visit our biology / biochemistry section for the latest news on this subject.
MLA
11 Feb. 2012. <http://www.medicalnewstoday.com/releases/179287.php>
APA
http://www.medicalnewstoday.com/releases/179287.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




